Samarth Kulkarni, Director at Black Diamond Therapeutics, holds ― shares in Black Diamond Therapeutics (Ticker: BDTX), holds ― shares in Repare Therapeutics (Ticker: RPTX), holds ― shares in Centessa Pharmaceuticals (Ticker: CNTA). Most recently, Samarth Kulkarni ― shares of Black Diamond Therapeutics on ― for an estimated value of ―.
Samarth Kulkarni latest transaction was an Uninformative Buy of ―.
What was Samarth Kulkarni's most profitable transaction?
Samarth Kulkarni’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Samarth Kulkarni's role in Black Diamond Therapeutics?
Samarth Kulkarni's role in Black Diamond Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.